Comparison of Steady-State Plasma Concentrations of Armodafinil and Modafinil Late in the Day Following Morning Administration

[1]  K. Wesnes,et al.  Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study , 2009 .

[2]  Anika Ashok,et al.  ICH Harmonised Tripartite Guideline , 2009 .

[3]  T. Roth,et al.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea , 2007, Sleep and Breathing.

[4]  M. Hirshkowitz,et al.  Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. , 2007, Respiratory medicine.

[5]  D. White,et al.  Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. , 2006, Clinical therapeutics.

[6]  J. Harsh,et al.  The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy* , 2006, Current medical research and opinion.

[7]  D. Dinges,et al.  Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss* , 2006, Current medical research and opinion.

[8]  N. Feldman,et al.  Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[9]  A. Somogyi,et al.  Inside the isomers: the tale of chiral switches , 2004 .

[10]  R. Hughes,et al.  Effects of Modafinil on Wakefulness and Executive Function in Patients With Narcolepsy Experiencing Late-Day Sleepiness , 2004, Clinical neuropharmacology.

[11]  N. Feldman,et al.  Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy , 2003, Clinical neuropharmacology.

[12]  C. DeVane,et al.  Great Expectations in Stereochemistry: Focus on Antidepressants , 2002, CNS Spectrums.

[13]  N. Rege,et al.  ICH Harmonised Tripartite Guideline: guideline for good clinical practice. , 2001, Journal of postgraduate medicine.

[14]  S. Ekins,et al.  (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[15]  Y. Wong,et al.  Open‐Label, Single‐Dose Pharmacokinetic Study of Modafinil Tablets: Influence of Age and Gender in Normal Subjects , 1999, Journal of clinical pharmacology.

[16]  Y. Wong,et al.  A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers , 1999, Journal of clinical pharmacology.

[17]  E. Hellriegel,et al.  Pharmacokinetic Profile of Armodafinil in Healthy Subjects , 2009, Clinical drug investigation.

[18]  K. Bogeso,et al.  The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer , 2005, Journal of Neural Transmission / General Section JNT.

[19]  E. Hellriegel,et al.  Clinical Pharmacokinetic Profile of Modafinil , 2003, Clinical pharmacokinetics.